[{"AccountsPayableCurrent_0_Q2_USD":3649734.0,"ShareBasedCompensation_1_Q2_USD":1700753.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.9761,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0168,"Cash_0_Q2_USD":26563071.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-195439.0,"LeaseAndRentalExpense_2_Q2_USD":110915.0,"LeaseAndRentalExpense_1_Q2_USD":60861.0,"PrepaidExpenseCurrent_0_Q2_USD":305559.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":9214.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":null,"NonoperatingIncomeExpense_2_Q2_USD":1654483.0,"NonoperatingIncomeExpense_1_Q2_USD":536492.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":null,"ShareBasedCompensation_2_Q2_USD":2965177.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1062755.0,"StockIssuedDuringPeriodValueAcquisitions_2_Q2_USD":15365492.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":4367540.0,"IncomeTaxesReceivable_0_Q2_USD":4151947.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":1509202.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_Q2_shares":10486266.0,"InterestIncomeExpenseNet_2_Q2_USD":116900.0,"InterestIncomeExpenseNet_1_Q2_USD":70180.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2965177.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1700753.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":500000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-272848.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-325960.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":2965177.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1700753.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":171958462.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6053047.0,"ResearchAndDevelopmentExpense_2_Q2_USD":12401715.0,"PreferredStockValue_0_Q2_USD":null,"Assets_0_Q2_USD":31020577.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":26563071.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":4377441.0,"CommonStockSharesIssued_0_Q2_shares":58664946.0,"CommonStockSharesOutstanding_0_Q2_shares":58664946.0,"CommonStockValue_0_Q2_USD":58666.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.24,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.12,"GeneralAndAdministrativeExpense_2_Q2_USD":3072176.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1720142.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-13819408.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-7236697.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":126402.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":31020577.0,"LiabilitiesCurrent_0_Q2_USD":6228831.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":15365492.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10988051.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingExpenses_1_Q2_USD":7773189.0,"OperatingExpenses_2_Q2_USD":15473891.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_2_Q2_USD":717328.0,"AccruedLiabilitiesCurrent_0_Q2_USD":2579097.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":56554037.0,"StockholdersEquity_0_Q2_USD":24791746.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-147225382.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":15365492.0,"NetIncomeLoss_1_Q2_USD":-7236697.0,"NetIncomeLoss_2_Q2_USD":-13828622.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":58353954.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_1_Q2_USD":510990.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]